BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2542170)

  • 1. Effects of dilazep in evolving myocardial infarction in dogs: a biochemical study.
    Gupta JB; Seth SD; Singh U; Vyas DS
    Int J Cardiol; 1989 May; 23(2):165-71. PubMed ID: 2542170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart.
    Hoque AN; Hoque N; Hashizume H; Abiko Y
    Jpn J Pharmacol; 1995 Mar; 67(3):225-32. PubMed ID: 7630040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of myocardial protective action of dilazep during ischaemia and reperfusion.
    Cargnoni A; Condorelli E; Ceconi C; Curello S; Albertini A; Ferrari R
    Pharmacol Res Commun; 1987 May; 19(5):341-57. PubMed ID: 3628458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dilazep and SG 75 on cyclic nucleotides in the coronary artery.
    Kobayashi A; Ogawa K; Yamazaki N
    Jpn Heart J; 1980 Jan; 21(1):85-94. PubMed ID: 6245291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dilazep on reperfusion arrhythmias.
    Sugiyama S; Kondo T; Ajioka M; Hattori M; Nagai S; Ozawa T
    Arzneimittelforschung; 1985; 35(12):1802-4. PubMed ID: 4096732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dilazep on decrease in myocardial pH during ischemia in dogs.
    Haga N; Miura I; Fujisawa Y; Fukushi Y; Abiko Y
    Arzneimittelforschung; 1986 Jun; 36(6):913-6. PubMed ID: 3741523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of membrane phospholipid and mitochondrial dysfunction associated with coronary reperfusion.
    Hattori M; Ogawa K; Satake T; Sugiyama S; Ozawa T
    Basic Res Cardiol; 1985; 80(3):241-50. PubMed ID: 4026784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator.
    Saito D; Kusachi S; Nagashima H; Haraoka S
    Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
    Hoque AN; Hoque N; Hashizume H; Abiko Y
    Jpn J Pharmacol; 1995 Mar; 67(3):233-41. PubMed ID: 7630041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial metabolism and heart disease.
    Opie LH
    Jpn Circ J; 1978 Nov; 42(11):1223-47. PubMed ID: 34741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of adenosine compounds of the vascular bed and effects of dilazep, theophylline, and indomethacin on blood flow changes of the postocclusive renal vessels].
    Ohtaki Y; Nakanishi H; Ueda J
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):93-102. PubMed ID: 558949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogs.
    Sakai K; Ichihara K; Nasa Y; Kamigaki M; Abiko Y
    Arch Int Pharmacodyn Ther; 1990; 307():92-108. PubMed ID: 2095718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dilazep on regional myocardial blood flow during selective coronary hypotension.
    Fujii M; Kikuchi Y; Koyanagi S; Okamatsu S; Tomoike H; Nakamura M
    Arzneimittelforschung; 1981; 31(12):2067-71. PubMed ID: 7199300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial metabolic effects of methylprednisolone sodium succinate in acute myocardial ischemia.
    Masters TN; Harbold NB; Hall DG; Jackson RD; Mullen DC; Daugherty HK; Robicsek F
    Am J Cardiol; 1976 Mar; 37(4):557-63. PubMed ID: 1258793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dilazep on myocardial contractility following acute ischemia and reperfusion in isolated blood-perfused canine left ventricular muscle.
    Shida H; Kobayashi M; Chiba S
    Jpn Heart J; 1981 Jul; 22(4):665-78. PubMed ID: 6457922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Agents to improve cerebrovascular circulation and cerebral metabolism--ATP and dilazep].
    Terashi A; Shimizu J
    Nihon Rinsho; 1985 Feb; 43(2):365-7. PubMed ID: 2987570
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myocardial protection by dilazep in myocardial ischemia and reperfusion].
    Shida H; Kobayashi M; Chiba S
    Arzneimittelforschung; 1981; 31(11):1902-6. PubMed ID: 7198472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium entry blocking activity of dilazep in dog coronary artery.
    Nakagawa Y; Gudenzi M; Mustafa SJ
    Pharmacology; 1986; 33(3):148-56. PubMed ID: 3018802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by dilazep on the negative inotropic effect of adenosine on guinea-pig atria.
    Fujita S; Ishida Y; Izumi K; Moritoki H; Ohara M; Takei M
    Br J Pharmacol; 1980 Feb; 68(2):343-9. PubMed ID: 7357212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxing effects of dilazep and lidoflazine in dog cerebral and renal arteries independent of adenosine.
    Mustafa SJ; Nakagawa Y
    Pharmacology; 1988; 37(2):75-84. PubMed ID: 3212039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.